Opioid analgesic

60 marketed 34 in Phase 3 4 in Phase 2 1 in Phase 1

This page covers all Opioid analgesic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Opioid receptors (mu, delta, kappa), Mu (μ) opioid receptor, Mu-opioid receptor (μ-OR).

Targets

Opioid receptors (mu, delta, kappa) · Mu (μ) opioid receptor · Mu-opioid receptor (μ-OR) · mu-opioid receptor · Mu-opioid receptor (OPRM1) · Mu opioid receptor (μ-OR) · Mu opioid receptor (primary); delta and kappa opioid receptors (secondary) · Mu-opioid receptor (μ-opioid receptor) · Mu-opioid receptor (OPRM1); tapentadol also targets norepinephrine transporter (SLC6A2) · Mu-opioid receptor

Marketed (60)

Phase 3 pipeline (34)

Phase 2 pipeline (4)

Phase 1 pipeline (1)